SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-20-010885
Filing Date
2020-05-15
Accepted
2020-05-15 08:46:24
Documents
47
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cbli20200331_10q.htm 10-Q 621293
2 EXHIBIT 31.1 ex_173016.htm EX-31.1 12892
3 EXHIBIT 32.1 ex_173017.htm EX-32.1 7444
  Complete submission text file 0001437749-20-010885.txt   3281397

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT cbli-20200331.xml EX-101.INS 603202
5 XBRL TAXONOMY EXTENSION SCHEMA cbli-20200331.xsd EX-101.SCH 36801
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbli-20200331_cal.xml EX-101.CAL 29040
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbli-20200331_def.xml EX-101.DEF 235686
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbli-20200331_lab.xml EX-101.LAB 237279
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbli-20200331_pre.xml EX-101.PRE 258345
Mailing Address 73 HIGH STREET BUFFALO NY 14203
Business Address 73 HIGH STREET BUFFALO NY 14203 (716) 849-6810
CLEVELAND BIOLABS INC (Filer) CIK: 0001318641 (see all company filings)

IRS No.: 200077155 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32954 | Film No.: 20880825
SIC: 8731 Services-Commercial Physical & Biological Research